ACS Biomarker

ACS Biomarker is a specialized biotechnology company focused on the development and validation of novel biomarkers for cardiovascular diseases, particularly heart failure. Founded as a spin-off from the Amsterdam University Medical Center, the company leverages extensive clinical biobanks and expertise in microRNA and protein analysis to identify diagnostic and prognostic markers. Their lead programs include microRNA-based assays designed to improve the diagnosis and management of heart failure patients. In addition to its internal pipeline, ACS Biomarker offers specialized biomarker services to pharmaceutical companies to enhance clinical trial design and patient stratification. The company's platform integrates clinical data with molecular profiling to accelerate the translation of research findings into clinical practice. By providing more precise diagnostic tools, ACS Biomarker aims to reduce the global burden of cardiovascular disease through personalized medicine.